Title:
QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/063855
Kind Code:
A1
Abstract:
Disclosed are a series of quinolino-pyrrolidin-2-one compounds, and application thereof in preparation of drugs for ATM inhibitor-related diseases. The present disclosure specifically relates to a derivative compound represented by formula (I), tautomers thereof or pharmaceutically acceptable compositions thereof. (I)
Inventors:
QIAN WENYUAN (CN)
YANG CHUNDAO (CN)
DAI GUOQIANG (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
YANG CHUNDAO (CN)
DAI GUOQIANG (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2019/108520
Publication Date:
April 02, 2020
Filing Date:
September 27, 2019
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D471/04; A61K31/444; A61K31/4545; A61K31/551; A61P35/00; C07D491/20
Domestic Patent References:
| WO2017194632A1 | 2017-11-16 | |||
| WO2009155527A2 | 2009-12-23 |
Foreign References:
| CN108349971A | 2018-07-31 | |||
| CN108348515A | 2018-07-31 | |||
| CN107889488A | 2018-04-06 | |||
| CN102399218A | 2012-04-04 | |||
| CN201811157825A | 2018-09-30 |
Other References:
See also references of EP 3845532A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: QUINOLINE-BASED DERIVATIVES AS VAP-1 INHIBITORS
Next Patent: 3,9- DIAZASPIRO[5,5] UNDECANE COMPOUND AS FLT3 AND AXL INHIBITORS
Next Patent: 3,9- DIAZASPIRO[5,5] UNDECANE COMPOUND AS FLT3 AND AXL INHIBITORS